Ekso Bionics Holdings, Inc. Common Stock
EKSOEkso Bionics Holdings, Inc. develops and manufactures wearable robotic exoskeletons designed to assist mobility for patients with neurological or orthopedic conditions. The company's exoskeletons are used in rehabilitation hospitals, clinical settings, and by industrial workers, aiming to enhance mobility, strength, and endurance. Founded in 2005, Ekso Bionics focuses on innovative robotic systems that support physical therapy and improve quality of life.
Company News
The global physical AI market is projected to grow from $4.12 billion in 2024 to $61.19 billion by 2034, with a 31.26% CAGR, driven by advances in robotics, AI-enabled surgery, and automation across healthcare, manufacturing, and logistics sectors.
Ekso Bionics reported a challenging Q2 2025, with revenue dropping 58% to $2.1 million, missing analyst expectations. The company experienced delays in Enterprise Health device sales, reduced gross margins, and continued net losses, though showing growth in personal device segments.
Ekso Bionics (EKSO) announces a research partnership with Shepherd Center to create training and research programs for the Ekso devices.
The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable i...
